Search

The surgical removal of the ovaries has been widely adopted as a cancer-risk-reducing strategy for women with either BRCA1 or BRCA2 mutations. A new multicenter study led by researchers at Memorial Sloan Kettering Cancer Center is the first prospective examination of the impact of this procedure in which BRCA2 mutation carriers were analyzed separately from BRCA1 mutation carriers.

… Monday, February 11, 2008 The surgical removal of the ovaries has been widely adopted as a cancer-risk-reducing strategy for women with either BRCA1 or BRCA2 mutations. A new multicenter study led by researchers at Memorial Sloan Kettering Cancer Center (MSKCC) is the first prospective examination of

Memorial Sloan Kettering Cancer Center (MSK) today announced the largest single donation in its nearly 150-year history, a $400 million gift from Kenneth C. Griffin, Founder and Chief Executive Officer of Citadel and Founder of Griffin Catalyst, and David Geffen, Founder of The David Geffen Foundation. It will serve as the cornerstone of MSK’s foundation for the future and will be instrumental in extending the power and potential of cancer care and treatment to people across New York and around the world as MSK continues to advance cutting-edge research and new cancer treatments.

… Tuesday, December 12, 2023 Donation To Enhance Care, Treatment, and Outcomes for People Across New York and Around the World Memorial Sloan Kettering Cancer Center (MSK) today announced the largest single donation in its nearly 150-year history, a $400 million gift from Kenneth C. Griffin, Founder and

Louis V. Gerstner, Jr. makes a generous $25 million commitment to establish the Louis V. Gerstner, Jr. Physician Scholars Program.

… Wednesday, September 29, 2021 Memorial Sloan Kettering Cancer Center (MSK) today announced a $25 million gift from Louis V. Gerstner, Jr. to create the Louis V. Gerstner, Jr. Physician Scholars Program . Designed to support the innovative research of physician-scientists who are early in their career

Tom Scalera and Brett Ravage found a second chance at love through the MSK community after losing their spouses to cancer in 2019. Together, they have raised more than $10 million for cancer research.

… Friday, June 6, 2025 It was a magical late autumn evening last year, in the heart of a charming Connecticut town. Family and friends had gathered to celebrate the marriage of Brett Ravage and Tom Scalera, a beautiful couple getting a second chance at love.   But what makes Brett and Tom’s wedding extraordinary

Honors were conferred, PhD degrees were awarded, and a Pulitzer Prize-winning author addressed the graduates at the May 10 ceremony.

… Monday, July 8, 2013 Summary Honors were conferred, PhD degrees were awarded, and a Pulitzer Prize-winning author addressed the graduates at the May 10 ceremony. Pictured: 2013 Graduates The 2013 graduates of the Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences Pictured: Siddhartha Mukerjee

Learn from MSK experts what people over 26 should know about getting the HPV vaccine to protect themselves from several forms of cancer.

… Friday, February 28, 2025 Summary U.S. health officials have expanded the recommended age range for people receiving the HPV vaccine to protect against several types of cancer to people in their mid-40s. MSK physicians offers advice for people considering the vaccine in their 20s, 30s, and 40s. The approved

A multidisciplinary team of Memorial Sloan Kettering investigators has shown for the first time that the gene that causes the inherited form of Parkinson's disease also plays a role in many types of cancer, including colon and lung cancers and glioblastoma, the most common form of brain cancer.

… Monday, February 1, 2010 Summary A multidisciplinary team of Memorial Sloan Kettering investigators has shown for the first time that the gene that causes the inherited form of Parkinson’s disease also plays a role in many types of cancer, including colon and lung cancers and glioblastoma, the most common

New drugs are being developed that target part of the process to make proteins.

… Wednesday, July 18, 2018 Summary Research into how proteins are made is being used for a possible new treatment for blood cancers. Cancer is a disease of the genes. But genes don’t directly cause the uncontrolled cell growth that characterizes the disease — proteins produced by those genes do. Consequently

Prostate cancer patients who are prescribed oral erectile medication before and after radiation therapy have improved sexual function, according to a research team at Memorial Sloan Kettering Cancer Center.

… Monday, October 29, 2012 Prostate cancer patients who are prescribed oral erectile medication before and after radiation therapy have improved sexual function, according to a research team at Memorial Sloan Kettering Cancer Center. This prospective, randomized, double-blind study is the first to analyze

The pictures provide new clues about how the androgen receptor interacts with cancer-causing proteins.

… Wednesday, April 20, 2022 Scientists at Memorial Sloan Kettering Cancer Center (MSK) have glimpsed never-before-seen details of the human androgen receptor — the protein inside of cells that responds to male-typical hormones like testosterone. Their research, published April 20, 2022, in the journal